VEGFA and preeclampsia: Accordingly, an excess of circulating sFlt-1 may partly contribute to the development and progression of preeclampsia by antagonizing the activity of vascular endothelial growth factor (VEGF) and placental growth factor (PlGF), leading to maternal endothelial dysfunction, which causes hypertension and proteinuria.